Option Care Health (NASDAQ:OPCH) Issues FY 2025 Earnings Guidance

Option Care Health (NASDAQ:OPCH) updated its FY 2025 earnings guidance on Tuesday. The company provided EPS guidance of 1.610-1.700 for the period, compared to the consensus EPS estimate of 1.630. The company issued revenue guidance of $5.4 billion-$5.6 billion, compared to the consensus revenue estimate of $5.4 billion.

Analyst Ratings Changes

Several research analysts have recently commented on the stock. JMP Securities reaffirmed a “market outperform” rating and set a $36.00 target price on shares of Option Care Health in a report on Tuesday, April 22nd. JPMorgan Chase & Co. lifted their price objective on shares of Option Care Health from $40.00 to $41.00 and gave the company an “overweight” rating in a research note on Thursday, March 6th. Bank of America raised shares of Option Care Health from a “neutral” rating to a “buy” rating and lifted their price objective for the company from $26.00 to $33.00 in a research note on Monday, January 13th. Barrington Research reissued an “outperform” rating and issued a $38.00 price objective on shares of Option Care Health in a research note on Monday, April 21st. Finally, Jefferies Financial Group raised shares of Option Care Health from a “hold” rating to a “buy” rating and lifted their price objective for the company from $26.00 to $35.00 in a research note on Thursday, January 23rd. Two investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat.com, Option Care Health currently has a consensus rating of “Moderate Buy” and an average price target of $33.75.

Option Care Health Price Performance

Shares of NASDAQ:OPCH opened at $32.97 on Tuesday. The firm has a market cap of $5.42 billion, a PE ratio of 27.71, a price-to-earnings-growth ratio of 2.30 and a beta of 1.07. The firm’s fifty day moving average is $33.37 and its 200-day moving average is $28.78. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. Option Care Health has a 52 week low of $21.39 and a 52 week high of $35.53.

Option Care Health (NASDAQ:OPCH) last released its earnings results on Tuesday, April 29th. The company reported $0.36 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.36. Option Care Health had a net margin of 4.37% and a return on equity of 15.30%. Sell-side analysts predict that Option Care Health will post 1.22 earnings per share for the current year.

Insider Activity

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the firm’s stock in a transaction that occurred on Friday, February 28th. The stock was sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the sale, the insider now owns 44,974 shares of the company’s stock, valued at approximately $1,495,835.24. This trade represents a 40.80 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Company insiders own 0.64% of the company’s stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.